EUCTR2015-001635-21-SE进行中（未招募）1 期
ordic pancreatic cancer trial (NorPACT) - 1 - NorPACT-1
Swedish studygroup for pancreatic cancer (SSPAC)0 个研究点目标入组 126 人开始时间: 2018年10月9日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 126
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Resectable tumour of the pancreatic head radiologically strongly suspect of pancreatic adenocarcinoma
- •T1-3, Nx, M0 (UICC 7th version, 2010)
- •age > 18 year and considered fit for major surgery
- •written informed consent
- •considered able to receive the study specific chemotherapy
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 126
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 126
排除标准
- •Matstatic disease
- •Non-resectable primary pancreatic cancer
研究者
相似试验
进行中（未招募）
1 期
ordic Pancreatic Cancer TrialResectable pancreatic cancerMedDRA version: 21.0Level: LLTClassification code 10033604Term: Pancreatic cancerSystem Organ Class: 100000004864EUCTR2015-001635-21-DKorwegian Gastointestinal Cancer Group140
进行中（未招募）
不适用
orwegian Pancreatic Cancer TrialResectable pancreatic cancerMedDRA version: 18.0Level: LLTClassification code 10033604Term: Pancreatic cancerSystem Organ Class: 100000004864EUCTR2015-001635-21-NOorwegian Gastointestinal Cancer Group
进行中（未招募）
不适用
A trial comparing the current standard treatment (gemcitabine) to the experimental, combined treatments of gemcitabine plus capecitabine.Resectable pancreatic or peri-ampullary cancersMedDRA version: 14.1Level: LLTClassification code 10033602Term: Pancreatic adenocarcinoma resectableSystem Organ Class: 100000004864MedDRA version: 14.1Level: LLTClassification code 10034446Term: Periampullary carcinoma resectableSystem Organ Class: 100000004864EUCTR2007-004299-38-GBThe University of Liverpool1,396
进行中（未招募）
1 期
Comparing Gemcetabine and Capecitabine versus Gemcitabine monotherapy in chemotherapy for pancreatic cancerResectable pancreatic cancerMedDRA version: 21.0Level: LLTClassification code 10033602Term: Pancreatic adenocarcinoma resectableSystem Organ Class: 100000004864EUCTR2007-004299-38-DEThe University of Liverpool1,068
进行中（未招募）
1 期
European Study Group for Pancreatic Cancer - Trial 4. Combination versus single agent adjuvant chemotherapy in resectable pancreatic cancer. - ESPAC-4Resectable pancreatic cancerMedDRA version: 14.1Level: LLTClassification code 10033602Term: Pancreatic adenocarcinoma resectableSystem Organ Class: 100000004864EUCTR2007-004299-38-SEThe University of Liverpool1,080